IndyCar Driver Pippa Mann Discusses BREVAGenplus

 

BREVAGenplus / Pippa Mann in the Media

BREVAGenplus / Pippa Mann Closing Bell Ceremony
BREVAGenplus / Pippa Mann Closing Bell Ceremony
BREVAGenplus / Pippa Mann Closing Bell Ceremony
BREVAGenplus / Pippa Mann Closing Bell Ceremony - Business News Network
Eutillio Buccilli and Pippa Mann posing with Susan G Komen New York City Affiliate
Pippa Mann and her racing car
Pippa Mann and her racing car
Pippa Mann and her racing car
 

Start By Being Proactive

When diagnosed early, the survival rate for breast cancer is over 98% percent. However, when detected at later stages, survival drops to just 41%. The key to beating the disease is early detection and putting a Breast Health Plan into place that is based on your individual risk.
What is BREVAGenplus?
BREVAGenplus is a test that determines your risk of developing breast cancer over the next 5 years and over the course of your lifetime.

Patient Questionnaire

In just a few minutes, see if you are a candidate for using BREVAGenplus to determine your risk of developing breast cancer.